Français
ORTHOPEDIC LINE – INJECTIONS
PLAYAL® 20 mg/2mL
Concentration of the formulation: 1,0 % of high molecular weight Sodium Hyaluronate (1.8 – 2.6 Mda) and 0,8% of Niacinamide
Syringe Volume: 2 mL
Administration cycle: 3 to 5 injections (under medical advice)
PLAYAL® 30 mg/2mL
Concentration of the formulation: 1,5 % of high molecular weight Sodium Hyaluronate (1.8 – 2.6 Mda) and 0,8% of Niacinamide
Syringe Volume: 2 mL
Administration cycle: 3 injections (under medical advice)
PLAYAL® 36 mg/2mL
Concentration of the formulation: 1,8 % of high molecular weight Sodium Hyaluronate (1.8 – 2.6 Mda) and 0,8% of Niacinamide
Syringe Volume: 2 mL
Administration cycle: 3 injections (under medical advice)
PLAYAL® 40 mg/2mL
Concentration of the formulation: 2,0 % of high molecular weight Sodium Hyaluronate (1.8 – 2.6 Mda) and 0,8% of Niacinamide
Syringe Volume: 2 mL
Administration cycle: 3 injections (under medical advice)
PLAYAL® 80 mg/4 mL
Concentration of the formulation: 2,0 % of high molecular weight Sodium Hyaluronate (1.8 – 2.6 Mda) and 0,5% of Niacinamide
Syringe Volume: 4 mL
Administration cycle: 1 injections (under medical advice)
